Treatment of tumors using specific anti-L1 antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8580258
APP PUB NO 20120258039A1
SERIAL NO

13367178

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTSIM NEUENHEIMER FELD 280 HEIDELBERG 69120

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Altevogt, Peter Nekargemund, DE 31 200
Brietling, Frank Heidelberg, DE 2 4
Kelm, Daniela Steinheim am der Murr, DE 4 6
Krueger, Achim Munich, DE 2 2
Li, Yi Wantage, GB 917 5421
Luettgau, Sandra Schongau, DE 2 2
Moebius, Ulrich Gauting, DE 21 68
Moldenhauer, Gerhard Heidelberg, DE 14 145
Schaefer, Heiner Kiel, DE 10 20
Sebens, Susanne Kiel, DE 2 2
Wolterink, Silke Weinheim, DE 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 12, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00